Page last updated: 2024-10-21

2,2'-azobis(2-amidinopropane) and Anemia, Hemolytic, Acquired

2,2'-azobis(2-amidinopropane) has been researched along with Anemia, Hemolytic, Acquired in 1 studies

2,2'-azobis(2-amidinopropane): water-soluble free-radical initiator

Research Excerpts

ExcerptRelevanceReference
"The extension of hemolysis is variable with erythrocyte samples, but 12."5.31Hemolysis of human erythrocytes induced by tamoxifen is related to disruption of membrane structure. ( Almeida, LM; Cruz Silva, MM; Custódio, JB; Madeira, VM, 2000)
"The extension of hemolysis is variable with erythrocyte samples, but 12."1.31Hemolysis of human erythrocytes induced by tamoxifen is related to disruption of membrane structure. ( Almeida, LM; Cruz Silva, MM; Custódio, JB; Madeira, VM, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cruz Silva, MM1
Madeira, VM1
Almeida, LM1
Custódio, JB1

Other Studies

1 other study available for 2,2'-azobis(2-amidinopropane) and Anemia, Hemolytic, Acquired

ArticleYear
Hemolysis of human erythrocytes induced by tamoxifen is related to disruption of membrane structure.
    Biochimica et biophysica acta, 2000, Mar-15, Volume: 1464, Issue:1

    Topics: Adult; Amidines; Anemia, Hemolytic; Cells, Cultured; Dose-Response Relationship, Drug; Erythrocyte M

2000